Michael A Nalesnik
Overview
Explore the profile of Michael A Nalesnik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
1429
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Demetris A, Lesniak A, Popp B, Frencho R, Minervini M, Nalesnik M, et al.
Am J Clin Pathol
. 2024 Feb;
161(6):543-552.
PMID: 38340346
Objectives: Pathologists interpreting kidney allograft biopsies using the Banff system usually start by recording component scores (eg, i, t, cg) using histopathologic criteria committed to memory. Component scores are then...
2.
Lacinski R, Dziadowicz S, Stewart A, Chaharbakhshi E, Akhter H, Pisquiy J, et al.
iScience
. 2024 Feb;
27(2):108836.
PMID: 38303687
Systemic administration of interleukin (IL)-12 induces potent anti-tumor immune responses in preclinical cancer models through the systemic activation of effector immune cells and release of proinflammatory cytokines. IL-12-loaded PLGA nanospheres...
3.
Kleiner D, Lisker-Melman M, Wahed A, Bhan A, Nalesnik M, Choi E, et al.
J Gastroenterol Hepatol
. 2023 Mar;
38(6):989-998.
PMID: 36890337
Background And Aim: Staining for hepatitis B viral antigens is often done in liver biopsies from patients with chronic hepatitis B, but its correlates with clinical phenotypes are not well...
4.
5.
Chung R, King W, Ghany M, Lisker-Melman M, Hinerman A, Khalili M, et al.
Clin Gastroenterol Hepatol
. 2022 Jan;
21(1):125-135.e8.
PMID: 34973459
Background & Aims: The contribution of the novel biomarkers, hepatitis B virus (HBV) RNA and HBV core-related antigen (HBcrAg), to characterization of HBV-human immunodeficiency virus (HIV) coinfection is unclear. We...
6.
Liu S, Nalesnik M, Singhi A, Wood-Trageser M, Randhawa P, Ren B, et al.
Hepatol Commun
. 2021 Nov;
6(4):710-727.
PMID: 34725972
Hepatocellular carcinoma (HCC) is one of the most lethal human cancers. Liver transplantation has been an effective approach to treat liver cancer. However, significant numbers of patients with HCC experience...
7.
van der Windt D, Wilson G, Ziogas I, Tohme S, Furlan A, Nalesnik M, et al.
Frontline Gastroenterol
. 2020 Oct;
11(6):501-502.
PMID: 33093938
No abstract available.
8.
Theodoropoulos N, La Hoz R, Wolfe C, Vece G, Bag R, Berry G, et al.
Transpl Infect Dis
. 2020 Sep;
23(1):e13458.
PMID: 32894634
Hepatitis B virus (HBV) can be transmitted from organ donor to recipient, but details of transmission events are not widely published. The Disease Transmission Advisory Committee (DTAC) evaluated 105 cases...
9.
Kaul D, Vece G, Blumberg E, La Hoz R, Ison M, Green M, et al.
Am J Transplant
. 2020 Jul;
21(2):689-702.
PMID: 32627325
Despite clinical and laboratory screening of potential donors for transmissible disease, unexpected transmission of disease from donor to recipient remains an inherent risk of organ transplantation. The Disease Transmission Advisory...
10.
Klompenhouwer A, Dwarkasing R, Doukas M, Pellegrino S, Vilgrain V, Paradis V, et al.
HPB (Oxford)
. 2019 Oct;
22(4):622-629.
PMID: 31619346
Background: Hepatic angiomyolipoma (HAML) may easily be misdiagnosed as a malignancy. The study aim was to assess diagnostic dilemmas, clinical management and outcome of this rare tumor. Methods: This retrospective...